{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:59:43Z","timestamp":1787950783837,"version":"build-2784847793"},"reference-count":273,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cca.2023.117742","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T12:06:28Z","timestamp":1704197188000},"page":"117742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Autoimmune inflammatory myopathy biomarkers"],"prefix":"10.1016","volume":"553","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2364-5517","authenticated-orcid":false,"given":"Mickael","family":"Essouma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cca.2023.117742_b0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.cca.2023.117742_b0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cca.2023.117742_b0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/BOR.0000000000000958","article-title":"Exploring challenges in the management and treatment of inclusion body myositis","volume":"35","author":"Skolka","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0025","unstructured":"World Health Organisation (WHO) International Programme on Chemical Safety (IPCS). Biomarkers and risk assessment: concepts and principles. Environmental Health Criteria 155. Environmental Health Criteria 155 (1993) 82, Biomarkers and risk assessment : concepts and principles (who.int)."},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0035","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/BOR.0000000000000652","article-title":"Genetics of idiopathic inflammatory myopathies: Insights into disease pathogenesis","volume":"31","author":"Rothwell","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2019","key":"10.1016\/j.cca.2023.117742_b0040","first-page":"9141420","article-title":"Biomarkers in adult dermatomyositis: Tools to help the diagnosis and predict the clinical outcome","volume":"2019","author":"Cassius","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"8","key":"10.1016\/j.cca.2023.117742_b0045","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/1756-185X.13353","article-title":"Emerging role of metabolomics in rheumatology","volume":"21","author":"Gupta","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.cca.2023.117742_b0050","doi-asserted-by":"crossref","unstructured":"E.S. Nakayasu M. Gritsenko P.D. Piehowski Y. Gao D.J. Orton A.A. Schepmoes T.L. Fillmore B.I. Frohnert M. Rewers J.P. Krischer C. Ansong A.M. Suchy Dicey C. Evans-Molina W.J. Qian B.J.M. Webb-Robertson T.O. Metz Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation. Nature Protocols 16 8 2021 3737 3760 10.1038\/s41596-021-00566-6.","DOI":"10.1038\/s41596-021-00566-6"},{"issue":"APR","key":"10.1016\/j.cca.2023.117742_b0055","first-page":"1","article-title":"A path to prediction of outcomes in juvenile idiopathic inflammatory myopathy","volume":"10","author":"Reed","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0090-1229(76)90145-8","article-title":"Description of a serological reaction characteristic of polymyositis","volume":"5","author":"Reichlin","year":"1976","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b0065","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10067-022-06437-z","article-title":"A bibliometric analysis of idiopathic inflammatory myopathies from 1982 to 2021","volume":"42","author":"Wu","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2023.117742_b0070","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fneur.2019.00554","article-title":"Biomarkers in inflammatory myopathies\u2014An expanded definition","volume":"10","author":"Benveniste","year":"2019","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/BOR.0000000000000641","article-title":"The role of cancer-associated autoantibodies as biomarkers in paraneoplastic myositis syndrome","volume":"31","author":"Lu","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/BOR.0000000000000749","article-title":"Monitoring disease activity and damage in adult and juvenile idiopathic inflammatory myopathy","volume":"32","author":"Gupta","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0085","doi-asserted-by":"crossref","unstructured":"M.P. Chung C. Richardson D. Kirakossian A.B. Orandi A. Saketkoo L.G. Rider A. Schiffenbauer C.A. von Mullen L. Chung & International Myositis Assessment Clinical Study group (IMACS) Clacinosis Scientific Interest Group. Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis Autoimmun Rev 19 6 2020 102533 10.1016\/j.autrev.2020.102533.","DOI":"10.1016\/j.autrev.2020.102533"},{"key":"10.1016\/j.cca.2023.117742_b0090","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/BOR.0000000000000744","article-title":"Cytokines and inflammatory mediators as promising markers of polymyositis\/dermatomyositis","volume":"32","author":"Cerezo","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0095","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12955","article-title":"The role of interferons type I, II and III in myositis: A review","volume":"31","author":"Bolko","year":"2021","journal-title":"Brain Pathol."},{"key":"10.1016\/j.cca.2023.117742_b0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/BOR.0000000000000816","article-title":"Updates on interferon in juvenile dermatomyositis: Pathogenesis and therapy","volume":"31","author":"Kim","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0105","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.rdc.2021.07.003","article-title":"Updates on juvenile dermatomyositis from the last decade: Classification to outcomes","volume":"47","author":"Kim","year":"2021","journal-title":"Rheum Dis Clin N Am"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12969-021-00637-8","article-title":"JAK inhibitors: A potential treatment for JDM in the context of the role of interferon-driven pathology","volume":"19","author":"Wilkinson","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/rir-2022-0001","article-title":"Myositis-specific antibodies: Overview and clinical utilization","volume":"3","author":"Halilu","year":"2022","journal-title":"Rheumatology and Immunology Research"},{"key":"10.1016\/j.cca.2023.117742_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886290","article-title":"The genetics of autoimmune myositis","volume":"13","author":"Lamb","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0125","doi-asserted-by":"crossref","unstructured":"S. Salam M.M. dimachkie M.G. Hanna P.M. Machado Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis. Clin Exp Rheumatol 40 2 2022 384 393 10.55563\/clinexprheumatol\/r625rm.","DOI":"10.55563\/clinexprheumatol\/r625rm"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/1744666X.2022.2021879","article-title":"Growth differentiation factor-15 as an emerging biomarker for identifying myositis","volume":"18","author":"De Pape","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11926-022-01076-4","article-title":"Update on biomarkers of vasculopathy in juvenile and adult myositis","volume":"24","author":"McLellan","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.cca.2023.117742_b0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/biom12010111","article-title":"Update on malignancy in myositis-well-established association with unmet needs","volume":"12","author":"Opinc","year":"2022","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.cca.2023.117742_b0145","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.3390\/ijms23084301","article-title":"Pathophysiological mechanisms and treatment of dermatomyositis and immune mediated necrotizing myopathies: A focused review","volume":"23","author":"Kamperman","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cca.2023.117742_b0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/BOR.0000000000000905","article-title":"Biomarkers of disease activity in dermatomyositis","volume":"34","author":"Lu","year":"2022","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0155","article-title":"The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives","volume":"22","author":"Gasparotto","year":"2023","journal-title":"A Literature Review. Autoimmunity Reviews"},{"key":"10.1016\/j.cca.2023.117742_b0160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jbusres.2019.07.039","article-title":"Literature review as a research methodology: An overview and guidelines","volume":"104","author":"Snyder","year":"2019","journal-title":"J. Bus. Res."},{"issue":"11","key":"10.1016\/j.cca.2023.117742_b0165","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","article-title":"Writing a narrative biomedical review: Considerations for authors, peer reviewers, and editors","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2023.117742_b0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13075-020-02210-2","article-title":"International myositis assessment and clinical studies (IMACS) group myositis autoantibody special interest group. The promise, perceptions and pitfalls of immunoassays for autoantibody testing in myositis","volume":"22","author":"Tansley","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.cca.2023.117742_b0175","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/rheumatology\/keab846","article-title":"Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis","volume":"61","author":"Karasawa","year":"2022","journal-title":"Rheumatology (bulgaria)"},{"key":"10.1016\/j.cca.2023.117742_b0180","first-page":"1","article-title":"Mechanism and complex roles of HSC70 in viral infections","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cca.2023.117742_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpubh.2017.00307","article-title":"Sensitivity, specificity, and predictive values: Foundations, pliabilities, and pitfalls in research and practice","volume":"5","author":"Trevethan","year":"2017","journal-title":"Front. Public Health"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0190","first-page":"627","article-title":"Receiver operating characteristic (ROC) Curve analysis for medical diagnostic test evaluation","volume":"4","author":"Hajian-Tilaki","year":"2013","journal-title":"Caspian J Intern Med."},{"key":"10.1016\/j.cca.2023.117742_b0195","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2016.11.006","article-title":"Splicing factor\/proline glutamine-rich is a novel autoantigen of dermatomyositis and is associated with anti-melanoma-differentiation associated gene 5 antibody","volume":"77","author":"Hosono","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cca.2023.117742_b0200","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1038\/s41388-020-1292-6","article-title":"Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity","volume":"39","author":"Pellarin","year":"2020","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0205","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/BOR.0000000000000837","article-title":"Polymyositis: Does it really exist as a distinct clinical subset?","volume":"33","author":"Leclair","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cca.2023.117742_b0210","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/rheumatology\/kez406","article-title":"Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis","volume":"59","author":"Betteridge","year":"2020","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15476286.2017.1391437","article-title":"eIF3: A factor for human health and disease","volume":"15","author":"Gomes-Duarte","year":"2018","journal-title":"RNA Biol."},{"issue":"10","key":"10.1016\/j.cca.2023.117742_b0220","first-page":"1","article-title":"Diagnostic test evaluation methodology: A systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard - An update","volume":"14","author":"Chikere","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.cca.2023.117742_b0225","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-216003","article-title":"Standardisation of myositis-specific antibodies: where are we today?","volume":"80","author":"Mahler","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.cca.2023.117742_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020266","article-title":"Autoantibodies against a 43 KDa Muscle Protein in Inclusion Body Myositis","volume":"6","author":"Salajegheh","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cca.2023.117742_b0235","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","article-title":"Inclusion body myositis: Clinical features and pathogenesis","volume":"15","author":"Greenberg","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0240","doi-asserted-by":"crossref","first-page":"384","DOI":"10.55563\/clinexprheumatol\/r625rm","article-title":"Diagnostic and prognostic value of anti-cN1A autoantibodies in inclusion body myositis","volume":"40","author":"Salam","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2023.117742_b0245","doi-asserted-by":"crossref","unstructured":"I. Mavroudis M. Knights F. Petridis S. Chatzikonstantinou E. Karantali D. Kazis Diagnostic Accuracy of Anti-CN1A on the Diagnosis of Inclusion Body Myositis. A Hierarchical Bivariate and Bayesian Meta-analysis. Journal of Clinical Neuromuscular Disease 23 1 2021 31 38 10.1097\/CND.0000000000000353.","DOI":"10.1097\/CND.0000000000000353"},{"key":"10.1016\/j.cca.2023.117742_b0250","doi-asserted-by":"crossref","unstructured":"J.B. Lilleker A. Rietveld S.R. Pye K. Mariampillai O. Benveniste M.T.J. Peeters J.A.L. Miller M.G. Hanna P.M. Machado M.J. Parton K.R. Gheorghe U.A. Badrising I.E. Lundberg S. Sacconi M.K. Herbert N.J. McHugh B.R.F. Lecky C. Brierley D. Hilton-Jones J.A. Lamb M.E. Roberts R.G. Cooper C.G.J. Saris G.J.M. Prujin H. Chinoy B.G.M. van Engelen & all UKMYONET contributors. Cytosolic 50-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis Ann Rheum Dis 76 2017 862 868 10.1136\/annrheumdis-2016-210282.","DOI":"10.1136\/annrheumdis-2016-210282"},{"key":"10.1016\/j.cca.2023.117742_b0255","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cca.2023.117742_b0260","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","article-title":"Sarcoplasmic MxA expression: A valuable marker of dermatomyositis","volume":"88","author":"Uruha","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.cca.2023.117742_b0265","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41374-019-0233-x","article-title":"Association between TDP-43 and mitochondria in inclusion body myositis","volume":"99","author":"Huntley","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/j.cca.2023.117742_b0270","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: Integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.cca.2023.117742_b0275","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","article-title":"TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia","volume":"79","author":"Weihl","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2023.117742_b0280","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cca.2023.117742_b0285","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb Perspect Biol."},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0290","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res"},{"issue":"7586","key":"10.1016\/j.cca.2023.117742_b0295","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature17041","article-title":"Protein misfolding in the endoplasmic reticulum as a conduit to human disease","volume":"529","author":"Wang","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b0300","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.semdp.2017.02.002","article-title":"Common spongiotic dermatoses","volume":"34","author":"Gru","year":"2017","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.cca.2023.117742_b0305","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cup.13880","article-title":"Increased MxA protein expression and dentritic cells in spongiotic dermatitis differentiate dermatomyositis from eczema in a single-center case-control study","volume":"48","author":"Zeidi","year":"2021","journal-title":"J Cutan Pathol."},{"key":"10.1016\/j.cca.2023.117742_b0310","doi-asserted-by":"crossref","unstructured":"A. P\u00e9rez-G\u00f3mez J. Vitall\u00e9 C. Gasca-Capote A. Gutierrez-Valencia M. Trujillo-Rodriguez A. Serna-Gallego E. Mu\u00f1oz-Muela M.L.R. Jim\u00e9nez-Leon M. Benhnia R.-J. Rafii-El-Idrissi C. Sotomayor C. Roca-Oporto N. Espinosa C. Infante-Dom\u00ednguez J.C. Crespo-Rivas A. Fern\u00e1ndez-Villar A. P\u00e9rez-Gonz\u00e1lez L.F. L\u00f3pez-Cort\u00e9s E. Poveda E. Ruiz-Mateos & Virgen del Roc\u00edo Hospital COVID-19 Working Team. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection Cell Mol Immunol 18 9 2021 2128 2139 10.1038\/s41423-021-00728-2.","DOI":"10.1101\/2021.03.18.436001"},{"key":"10.1016\/j.cca.2023.117742_b0315","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3899\/jrheum.220089","article-title":"Cutaneous involvement in systemic lupus erythematosus: a review for the Rheumatologist","volume":"50","author":"Stull","year":"2023","journal-title":"J. Rheumatol."},{"issue":"16","key":"10.1016\/j.cca.2023.117742_b0320","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139558","article-title":"IL18-containing 5-gene signature distinguishes histologically identical dermatomyositis and lupus erythematosus skin lesions","volume":"5","author":"Tsoi","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0325","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","article-title":"Pathway enrichment analysis and visualization of omics data using g: Profiler, GSEA cytoscape and enrichmentMap","volume":"14","author":"Reimand","year":"2019","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cca.2023.117742_b0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.cca.2023.117742_b0335","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.0022-202X.2005.23699.x","article-title":"Late cornified envelope family in differentiating epithelia\u2013response to calcium and ultraviolet irradiation","volume":"124","author":"Jackson","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cca.2023.117742_b0340","doi-asserted-by":"crossref","unstructured":"S.E. Lee S.H. Lee Skin barrier and calcium. Ann Dermatol 30 3 2018 265 275 10.5021\/ad.2018.30.3.265.","DOI":"10.5021\/ad.2018.30.3.265"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101768","article-title":"Calcinosis in dermatomyositis: Origins and possible therapeutic avenues","volume":"36","author":"Davuluri","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0350","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000131751","article-title":"Dermatomyositis","volume":"10","author":"Krathen","year":"2008","journal-title":"Curr Dir Autoimmun"},{"issue":"5","key":"10.1016\/j.cca.2023.117742_b0355","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000332221","article-title":"Evolution of treatment strategies for calciphylaxis","volume":"34","author":"Ross","year":"2011","journal-title":"Am J Nephrol"},{"issue":"47","key":"10.1016\/j.cca.2023.117742_b0360","doi-asserted-by":"crossref","first-page":"36909","DOI":"10.1074\/jbc.M110.161745","article-title":"Against the rules: human keratin K80: two functional alternative splice variants, K80 and K80.1, with special cellular localization in a wide range of epithelia","volume":"285","author":"Langbein","year":"2010","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.cca.2023.117742_b0365","doi-asserted-by":"crossref","first-page":"13295","DOI":"10.3390\/ijms241713295","article-title":"Research advances in the role of the tropomyosin family in cancer","volume":"24","author":"Meng","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cca.2023.117742_b0370","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-023-05377-4","article-title":"Long-standing and poorly controlled disease in juvenile dermatomyositis is associated with calcinosis: A real-world experience from a low-middle income country","author":"Mehta","year":"2023","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0375","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","article-title":"A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","volume":"60","author":"Selva-O'Callagan","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0380","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/RHU.0000000000001736","article-title":"Epidemiology of idiopathic inflammatory myopathies in africa A contemporary systematic review","volume":"28","author":"Essouma","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.747214","article-title":"Troponins variants as markers of skeletal muscle health and diseases","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cca.2023.117742_b0390","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9713326","article-title":"High-, Sensitivity troponin: A review on characteristics, assessment, and clinical implications","volume":"2022","author":"Lazar","year":"2022","journal-title":"Dis. Markers"},{"issue":"10","key":"10.1016\/j.cca.2023.117742_b0395","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1503\/cmaj\/051291","article-title":"Troponin: The biomarker of choice for the detection of cardiac injury","volume":"173","author":"Babuin","year":"2005","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0400","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/jalm\/jfz016","article-title":"Evaluation of a new skeletal troponin I assay in patients with idiopathic inflammatory myopathies","volume":"5","author":"Bamberg","year":"2020","journal-title":"J Appl Lab Med"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0405","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1373\/clinchem.2004.042671","article-title":"Fast and slow skeletal troponin I in serum from patients with various skeletal muscle disorders: A pilot study","volume":"51","author":"Simpson","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2023.117742_b0410","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/keab573","article-title":"Defining cardiac involvement in idiopathic inflammatory myopathies: A systematic review","volume":"61","author":"Fairley","year":"2022","journal-title":"Rheumatology"},{"issue":"22","key":"10.1016\/j.cca.2023.117742_b0415","first-page":"e368","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: A report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2023.117742_b0420","doi-asserted-by":"crossref","unstructured":"J-P. Collet H. Thiele E. Barbato O. Barthelemy J. Bauersachs D.L. Bhatt P. Dendale M. Dorobantu T. Edvardsen T. Folliguet C.P. Gale M. Gilard A. Jobs P. J\u00fcni E. Lambrinou B.S. Lewis J. Mehilli E. Meliga B. Merkely C. Mueller M. Roffi F.H Ruttenm D. Sibbing G.C.M. Siontis & ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42 14 2021 1289 1367 10.1093\/eurheartj\/ehaa575.","DOI":"10.15829\/1560-4071-2021-4418"},{"issue":"9","key":"10.1016\/j.cca.2023.117742_b0425","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jacc.2018.12.046","article-title":"Recommendations for institutions transitioning to high-sensitivity troponin testing","volume":"73","author":"Januzzi","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0430","doi-asserted-by":"crossref","first-page":"80","DOI":"10.14740\/jocmr4664","article-title":"False-positive causes in serum cardiac troponin levels","volume":"14","author":"Chaulin","year":"2022","journal-title":"J Clin Med Res"},{"issue":"11","key":"10.1016\/j.cca.2023.117742_b0435","article-title":"The effects of Hsp90\u03b11 mutations on myosin thick filament organization","volume":"10","author":"Schopf","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0440","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"10.1016\/j.cca.2023.117742_b0445","article-title":"Hsp90 levels in idiopathic inflammatory myopathies and their association with muscle involvement and disease activity: A cross-sectional and longitudinal study","volume":"28","author":"\u0160tork\u00e1nov\u00e1","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0450","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00296-016-3609-x","article-title":"Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy","volume":"37","author":"Xiao","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2023.117742_b0455","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cca.2015.02.031","article-title":"Soluble urokinase plasminogen activator receptor\u2014A valuable biomarker in systemic lupus erythematosus?","volume":"444","author":"Enocsson","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0460","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/rth2.12355","article-title":"Plasminogen activation in the musculoskeletal acute phase response: Injury, repair and disease","volume":"4","author":"Gibson","year":"2020","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.cca.2023.117742_b0465","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fonc.2019.00979","article-title":"The roles of TIF1\u03b3 in cancer","volume":"9","author":"Yu","year":"2019","journal-title":"Front Oncol."},{"issue":"10","key":"10.1016\/j.cca.2023.117742_b0470","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1195","article-title":"A novel autoantibody targeting calreticulin is associated with cancer in patients with idiopathic inflammatory myopathies","volume":"9","author":"Chen","year":"2020","journal-title":"Clin. Transl. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0475","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/2159-8290.CD-15-1434","article-title":"Mutant calreticulin requires both its mutant C-terminus and the thrombopoietin receptor for oncogenic transformation","volume":"6","author":"Elf","year":"2016","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.cca.2023.117742_b0480","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.18632\/aging.204098","article-title":"Identification of hub biomarkers and immune cell infiltration in polymyositis and dermatomyositis","volume":"14","author":"Chen","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cca.2023.117742_b0485","doi-asserted-by":"crossref","unstructured":"L. Wang D. Fang Y. Liu Autophagy-related genes are potential diagnostic biomarkers for dermatomyositis. Ann Transl Med 10 4 2022 228 10.21037\/atm-22-70.","DOI":"10.21037\/atm-22-70"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0490","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0495","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fimmu.2019.00325","article-title":"Regulating IRFs in IFN driven disease","volume":"19","author":"Jefferies","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.cca.2023.117742_b0500","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/v11080762","article-title":"Viruses and autoimmunity: A review on the potential interaction and molecular mechanisms","volume":"11","author":"Smatti","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.cca.2023.117742_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102506","article-title":"Autoinflammatory and autoimmune conditions at the crossroad of COVID19","volume":"114","author":"Rodriguez","year":"2020","journal-title":"J Autoimmun"},{"issue":"12","key":"10.1016\/j.cca.2023.117742_b0510","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0515","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41584-021-00606-1","article-title":"Interferon lambda in inflammation and autoimmune rheumatic diseases","volume":"17","author":"Goel","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0520","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard-2022-223628","article-title":"2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice","volume":"82","author":"Rodriguez-Carrio","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0525","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003211","article-title":"Assessment of type I interferon response in routine practice in France in 2022","volume":"9","author":"Nombel","year":"2023","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0530","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.cca.2023.117742_b0535","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41584-021-00694-z","article-title":"Targeting interferon-\u03b3 in hyperinflammation: Opportunities and challenges","volume":"17","author":"De Benedetti","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0540","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.cca.2023.117742_b0545","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: The biology of type III interferons","volume":"16","author":"Wack","year":"2015","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.cca.2023.117742_b0550","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/art.41236","article-title":"Endothelial and inflammation biomarker profiles at diagnosis reflecting clinical heterogeneity and serving as a prognostic tool for treatment response in two independent cohorts of patients with juvenile dermatomyositis","volume":"72","author":"Wienke","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b0555","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5606\/ArchRheumatol.2017.6175","article-title":"Serum interleukin-18 level is associated with disease activity and interstitial lung disease in patients with dermatomyositis","volume":"32","author":"Yang","year":"2017","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0560","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s10067-018-04418-9","article-title":"Serum-soluble TRAIL: A potential biomarker for disease activity in myositis patients","volume":"38","author":"Zhou","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2023.117742_b0565","doi-asserted-by":"crossref","unstructured":"D. Saygin P. Biswas S. Nouraie S. Moghadam-Kia M. McGeachy C. Oddis S. Dzanko D. Koontz D. Ascherman R. Aggarwal Serum Cytokine Profiles of Patients with Adult Idiopathic Inflammatory Myopathy [abstract]. Arthritis Rheumatol 73 suppl 9 2021 Accessed November 9, 2023 https:\/\/acrabstracts.org\/abstract\/serum-cytokine-profiles-of-patients-with-adult-idiopathic-inflammatory-myopathy\/.","DOI":"10.55563\/clinexprheumatol\/ipgoev"},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0570","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/1744666X.2022.2054803","article-title":"Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits","volume":"18","author":"Dalakas","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0575","first-page":"493","article-title":"Usefulness of the soluble membrane attack complex to determine dermatomyositis clinical activity and treatment response","volume":"154","author":"Tirado-Sanchez","year":"2018","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.cca.2023.117742_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102979","article-title":"The complement system and human autoimmune diseases","volume":"137","author":"Coss","year":"2023","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0585","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/ard-2022-222935","article-title":"& for MYOGEN Investigators. Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies","volume":"82","author":"Zhou","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0590","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity \u2014 Basic concepts and contributions to immunopathology","volume":"19","author":"Ochando","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cca.2023.117742_b0595","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12967-019-02176-z","article-title":"Correlation of PMN elastase and PMN elastase-to-neutrophil ratio with disease activity in patients with myositis","volume":"17","author":"Wu","year":"2019","journal-title":"Transl Med"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0600","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.41078","article-title":"Neutrophil extracellular traps in tissue and periphery in juvenile dermatomyositis","volume":"72","author":"Duvvuri","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0605","first-page":"33","article-title":"Myeloperoxidase as an active disease biomarker: Recent biochemical and pathological perspectives","volume":"6","author":"Khan","year":"2018","journal-title":"Med. Sci"},{"issue":"44","key":"10.1016\/j.cca.2023.117742_b0610","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2308511120","article-title":"The total mass, number, and distribution of immune cells in the human body","volume":"120","author":"Sender","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.cca.2023.117742_b0615","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.immuni.2021.06.006","article-title":"The neutrophil","volume":"54","author":"Burn","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.cca.2023.117742_b0620","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphys.2018.00113","article-title":"Neutrophil: A cell with many roles in inflammation or several cell types?","volume":"9","author":"Rosales","year":"2018","journal-title":"Front Physiol"},{"issue":"12","key":"10.1016\/j.cca.2023.117742_b0625","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.celrep.2015.11.055","article-title":"Type I interferon transcriptional signature in neutrophils and low-density granulocytes are associated with tissue damage in malaria","volume":"13","author":"Rocha","year":"2015","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b0630","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1165\/rcmb.2013-0316OC","article-title":"Mechanisms of interferon-\u03b3 production by neutrophils and its function during streptococcus pneumoniae pneumonia","volume":"52","author":"Gomez","year":"2015","journal-title":"Am J Resp Cell Mol Biol"},{"key":"10.1016\/j.cca.2023.117742_b0635","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-immunol-041015-055402","article-title":"Galectins and immune responses\u2014Just How Do They Do Those Things They Do?","volume":"34","author":"Thiemann","year":"2016","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0640","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","article-title":"Siglecs as immune cell checkpoints in disease","volume":"38","author":"Duan","year":"2020","journal-title":"Annu. Rev. Immunol"},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0645","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0650","doi-asserted-by":"crossref","unstructured":"T. Miyagi K. Yamaguchi Sialic Acids. In: Comprehensive Glycoscience\u2014From Chemistry to Systems Biology; J.P. Kamerling G.-J. Boons Y.C. Lee A. Suzuki N. Taniguchi A.G.J. Voragen Eds.; Vol. 3; Elsevier Ltd.: Oxford, UK, 2007 297 323.","DOI":"10.1016\/B978-044451967-2\/00055-6"},{"issue":"8","key":"10.1016\/j.cca.2023.117742_b0655","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.cca.2023.117742_b0660","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/art.40881","article-title":"Galectin-9 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: A longitudinal cohort study and multicohort validation","volume":"71","author":"Wienke","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0665","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/rheumatology\/keaa305","article-title":"Serum levels of Galectin-3 in idiopathic inflammatory myopathies: A potential biomarker of disease activity","volume":"60","author":"Watanabe","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2023.117742_b0670","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001934","article-title":"SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies","volume":"8","author":"Graf","year":"2022","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.cca.2023.117742_b0675","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/cr.2015.108","article-title":"Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27","volume":"25","author":"Zheng","year":"2015","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0680","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/art.23404","article-title":"Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus","volume":"58","author":"Biesen","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0685","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-virology-092917-043323","article-title":"TRIM proteins and their roles in antiviral host defenses","volume":"5","author":"van Gent","year":"2018","journal-title":"Annu Rev Virol"},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0690","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/nan.12498","article-title":"Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis","volume":"45","author":"Soponkanaporn","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0695","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1093\/rheumatology\/keab872","article-title":"Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type 1 interferonopathy","volume":"61","author":"Okada","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2023.117742_b0700","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-statistics-030718-105251","article-title":"Precision medicine","volume":"6","author":"Kosorok","year":"2019","journal-title":"Annu Rev Stat Appl"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0705","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/bib\/bby026","article-title":"Molecular subtyping of cancer: Current status and moving toward clinical applications","volume":"20","author":"Zhao","year":"2019","journal-title":"Brief Bioinform"},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b0710","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134189","article-title":"Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies","volume":"5","author":"Seto","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.cca.2023.117742_b0715","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1097\/RHU.0000000000001772","article-title":"Low-density granulocytes and neutrophil extracellular traps as biomarkers of disease activity in adult inflammatory myopathies","volume":"28","author":"Torres-Ruiz","year":"2022","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0720","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/14397595.2016.1179861","article-title":"Abnormally increased low-density granulocytes in peripheral blood mononuclear cells are associated with interstitial lung disease in dermatomyositis","volume":"27","author":"Zhang","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0725","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/diagnostics12010008","article-title":"Clues to disease activity in juvenile dermatomysoitis: Neopterin and other biomarkers","volume":"12","author":"Khojah","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.cca.2023.117742_b0730","article-title":"Aberrantly expressed Galectin-9 is involved in the immunopathogenesis of anti-MDA5 positive dermatomyositis associated interstitial lung disease","volume":"9","author":"Liang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cca.2023.117742_b0735","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41598-017-01685-5","article-title":"Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: A case-control study","volume":"7","author":"Oda","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cca.2023.117742_b0740","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3389\/fimmu.2018.01372","article-title":"CD19+CD24hiCD38hi B cells are expanded in juvenile dermatomyositis and exhibit a proinflammatory phenotype after activation through Toll-like Receptor 7 and inteferon-\u03b1","volume":"9","author":"Piper","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0745","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s41927-020-00150-7","article-title":"Serum protein biomarkers for juvenile dermatomyositis: A pilot study","volume":"4","author":"Tawalbeh","year":"2020","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0750","unstructured":"N. Ziade M. Aoude I. Hmamouchi R. Naveen J.B. Lilleker P. Sen M. Joshi V. Agarwal S. Kardes J. Day A. Makol M. Milchert T. Gheita B. Salim T. Velikova A.E. Gracia-Ramos I. Parodis E. Nikiphorou T. Chatterjee A.L. Tan M.A. Saavedra S.K. Shinjo J. Knitza M. Kuwana A. Nune L. Cavagna O. Distler H. Chinoy V. Agarwal R. Aggarwal L. Gupta and the COVAD study group. Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study. Rheumatology (Oxford) (2023) kead250. 10.1093\/rheumatology\/kead250."},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0755","first-page":"348","article-title":"Use of janus kinase inhibitors in dermatomyositis: A systematic literature review","volume":"41","author":"Paik","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0760","doi-asserted-by":"crossref","unstructured":"E.F. Morand R.A. Furie Y. Tanaka I.N. Bruce C. Askanase C. Richez S.-C. Bae P.Z. Brohawn L. Pineda A. Berglind R. Tummala for the TULI-2 trial investigators. Trial of anifrolumab in active systemic lupus erythematosus N Engl J Med 382 3 2020 211 221 10.1056\/NEJMoa1912196.","DOI":"10.1056\/NEJMoa1912196"},{"key":"10.1016\/j.cca.2023.117742_b0765","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/1346-8138.15117","article-title":"Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease","volume":"46","author":"Matsushita","year":"2019","journal-title":"J. Dermatol."},{"key":"10.1016\/j.cca.2023.117742_b0770","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6243019","article-title":"Soluble IL-2 receptor in dermatomyositis: Its association with skin ulcer and disease activity","volume":"2020","author":"He","year":"2020","journal-title":"Mediators Inflam"},{"key":"10.1016\/j.cca.2023.117742_b0775","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s10067-018-4046-x","article-title":"Serum BAFF in Indian patients with IIM: A retrospective study reveals novel clinicophenotypic associations in children and adults","volume":"37","author":"Gupta","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2023.117742_b0780","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead010","article-title":"Rituximab in myositis: where are we now? A survey of current usage","author":"Oliveira","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2023.117742_b0785","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.reuma.2022.03.002","article-title":"Peripheral T helper subset profiling in idiopathic inflammatory myositis: Proof of concept","volume":"19","author":"Anuja","year":"2023","journal-title":"Reumatol Clin"},{"issue":"9","key":"10.1016\/j.cca.2023.117742_b0790","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/pathogens10091091","article-title":"The enigma of low-density granulocytes in humans: Complexities in the characterization and function of LDGs during disease","volume":"10","author":"Seman","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.cca.2023.117742_b0795","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1622160","article-title":"Low-density granulocytes in immune-mediated inflammatory diseases","volume":"2022","author":"Ning","year":"2022","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.cca.2023.117742_b0800","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0805","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0625.2011.01413.x","article-title":"Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair","volume":"21","author":"Kuschal","year":"2011","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0810","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/nar\/gkaa1202","article-title":"DNA damage alters nuclear mechanics through chromatin reorganization","volume":"49","author":"dos Santos","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cca.2023.117742_b0815","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11010-021-04315-x","article-title":"Inhibition of NETosis for treatment purposes: Friend or foe?","volume":"477","author":"Chamardani","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cca.2023.117742_b0820","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/rheumatology\/keab601","article-title":"Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response","volume":"61","author":"Lerkvaleekul","year":"2022","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0825","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","article-title":"Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases","volume":"50","author":"Ishikawa","year":"2012","journal-title":"Respir Investig"},{"key":"10.1016\/j.cca.2023.117742_b0830","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1146\/annurev-biochem-011520-105053","article-title":"Mucins and the microbiome","volume":"89","author":"Hansson","year":"2020","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.cca.2023.117742_b0835","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fmed.2018.00018","article-title":"Surfactant protein D in respiratory and non-respiratory diseases","volume":"5","author":"Sorensesn","year":"2018","journal-title":"Front Med (lausanne)"},{"key":"10.1016\/j.cca.2023.117742_b0840","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12929-022-00790-6","article-title":"LRG1: an emerging player in disease pathogenesis","volume":"29","author":"Camilli","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0845","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14397595.2018.1553488","article-title":"KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis\/dermatomyositis, but is not a short-term disease-activity biomarker","volume":"29","author":"Hanaoka","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0850","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s10067-019-04501-9","article-title":"Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis","volume":"38","author":"Hu","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b0855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234090","article-title":"Correlation of serum leucin-rich \u03b1-2 glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study","volume":"15","author":"Ishida","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b0860","first-page":"373","article-title":"A systematic review and metaanalysis of predictors of mortality in idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"50","author":"Hannah","year":"2023","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2023.117742_b0865","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1146\/annurev-immunol-032414-112220","article-title":"Macrophages: Development and tissue specialization","volume":"33","author":"Varol","year":"2015","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0870","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage polarization: DifferentGene signatures in M1(LPS+) vs. Classically and M2(LPS\u2013) vs alternatively activated macrophages","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b0875","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2567.2008.02905.x","article-title":"Secretion of interferon-c by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18","volume":"126","author":"Darwich","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.cca.2023.117742_b0880","article-title":"Dictionary of immune responses to cytokines at single-cell resolution","author":"Cui","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cca.2023.117742_b0885","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/antiox7070080","article-title":"Neopterin, inflammation, and oxidative stress: what could we be missing?","volume":"7","author":"Gieseg","year":"2018","journal-title":"Antioxidants"},{"key":"10.1016\/j.cca.2023.117742_b0890","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury","volume":"73","author":"Lee","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.cca.2023.117742_b0895","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13075-018-1737-2","article-title":"Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis","volume":"20","author":"Ishikawa","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b0900","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/cei.13404","article-title":"A high level of serum neopterin is associated with rapidly progressive interstitial lung disease and reduced survival in dermatomyositis","volume":"199","author":"Peng","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cca.2023.117742_b0905","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-016-1214-8","article-title":"Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease","volume":"19","author":"Enomoto","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2023.117742_b0910","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7948095","article-title":"Increased levels of soluble CD206 associated with rapidly progressive interstitial lung disease in patients with dermatomyositis","author":"Shen","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cca.2023.117742_b0915","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3899\/jrheum.170373","article-title":"Clinical uitlity of YKL-40 in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"44","author":"Hozumi","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0920","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3899\/jrheum.180825","article-title":"Clinical significance of serum chitotriosidase level in anti-MDA5 antibody\u2013positive dermatomyositis-associated interstitial lung disease","volume":"46","author":"Fujisawa","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b0925","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez185","article-title":"Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD","author":"Horiike","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2023.117742_b0930","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3389\/fimmu.2017.01908","article-title":"S100 Proteins as an important regulator of macrophage inflammation","volume":"8","author":"Xia","year":"2018","journal-title":"Front Immunol"},{"issue":"43","key":"10.1016\/j.cca.2023.117742_b0935","doi-asserted-by":"crossref","first-page":"26895","DOI":"10.1073\/pnas.2011667117","article-title":"TLR4 signaling and macrophage inflammatory responses are dampened by GIV\/Girdin","volume":"117","author":"Swanson","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2023.117742_b0940","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12890-020-01226-3","article-title":"Serums levels of interleukins and S100A8\/A9 correlate with clinical severity in patients with dermatomyositis-associated interstitial lung disease","volume":"196","author":"Lou","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0945","first-page":"1","article-title":"Serum S100A12 are correlated with clinical severity in patients with dermatomyositis-associated interstitial lung disease","volume":"48","author":"Lou","year":"2019","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b0950","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/0004563218786979","article-title":"Elevated serum YKL-40 correlates with clinical characteristics in patients with polymyositis or dermatomyositis","volume":"56","author":"Gao","year":"2019","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2023.117742_b0955","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1038\/s41467-022-34145-4","article-title":"Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications","volume":"13","author":"Ye","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2023.117742_b0960","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/joim.13154","article-title":"IL-15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis\/dermatomyositis","volume":"289","author":"Shimizu","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2023.117742_b0965","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12890-018-0609-5","article-title":"Elevated \u03b1-defensins in plasma and bronchoalveolar lavage fluid of patients with myositis-associated interstitial lung disease","volume":"18","author":"Sakamoto","year":"2018","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.cca.2023.117742_b0970","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/key341","article-title":"CD4+CXCR4+ T cells as a novel biomarker in patients with idiopathic inflammatory myopaties-associated interstitial lung disease","volume":"58","author":"Wang","year":"2019","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.cca.2023.117742_b0975","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.21037\/jtd-20-651","article-title":"Bronchoalveolar lavage as a diagnostic procedure: A review of known cellular and molecular findings in various lung diseases","volume":"12","author":"Davidson","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.cca.2023.117742_b0980","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The Hyperferritinemic Syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"1","author":"Rosario","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.cca.2023.117742_b0985","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/rheumatology\/key006","article-title":"Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment","volume":"58","author":"Carter","year":"2019","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0990","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.rdc.2022.06.007","article-title":"Environmental risks for inflammatory myopathies","volume":"48","author":"Che","year":"2022","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b0995","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/annrheumdis-2017-212149","article-title":"Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis","volume":"77","author":"Kochi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2023.117742_b1000","doi-asserted-by":"crossref","unstructured":"S. Remuzgo-Martinez B. Atienza-Mateo J.G. Ocejo-Vinyals F. Genre V. Pulito-Cueto V.M. Mora-Cuesta D. Iturbe-Fern\u00e1ndez L. Lera-G\u00f3mez R. P\u00e9rez-Fern\u00e1ndez D. Prieto-Pe\u00f1a J. Irure F. Romero-Bueno O. Sanchez-Pernaute R. Alonso-Moralejo L. Nu\u00f1o G. Bonilla E.F. Vicente-Rabaneda I. Grafia S. Prieto Gonz\u00e1lez J. Narvaez E. Trallero-Araguas A. Selva-O'Callaghan Spanish Biomarkers of Antisynthetase Syndrome Consortium; Spanish Biomarkers of Interstitial Lung Disease Consortium; O. Gualillo L. Cavagna J.M. Cifri\u00e1n E.A. Renzoni S. Casta\u00f1eda R. L\u00f3pez-Mej\u00edas M.A. Gonz\u00e1lez-Gay Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome Sci Rep 11 1 2021 22574 10.1038\/s41598-021-01992-y.","DOI":"10.1038\/s41598-021-01992-y"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b1005","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1038\/s41598-022-09943-x","article-title":"The SNPs of mitochondrial DNA displacement loop region and mitochondrial DNA copy number associated with risk of polymyositis and dermatomyositis","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.cca.2023.117742_b1010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-017-0058-1","article-title":"Circulating plasma microRNA profiling in patients with polymyositis\/dermatomyositis before and after treatment: miRNA may be associated with polymyositis\/dermatomysoitis","volume":"38","author":"Hirai","year":"2018","journal-title":"Inflammation and Regeneration"},{"key":"10.1016\/j.cca.2023.117742_b1015","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/rheumatology\/keab753","article-title":"Plasma exosomal RNAs have potential as both clinical biomarkers and and therapeutic targets of dermatomyositis","volume":"61","author":"Li","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2023.117742_b1020","doi-asserted-by":"crossref","first-page":"6676107","DOI":"10.1155\/2021\/6676107","article-title":"Plasma-derived exosomal hsamiR-4488 and hsa-miR-1228-5p: Novel biomarkers for dermatomyositis-associated interstitial lung disease with anti-melanoma differentiation-associated protein 5 antibody-positive subset","volume":"2021","author":"Zhong","year":"2021","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b1025","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.41625","article-title":"From diagnosis to prognosis: Revisiting the meaning of muscle ISG15 overexpression in juvenile inflammatory myopathies","volume":"73","author":"Hou","year":"2021","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.cca.2023.117742_b1030","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/bjd.15006","article-title":"Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon \u03b2in dermatomyositis","volume":"176","author":"Huard","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cca.2023.117742_b1035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13075-020-02160-9","article-title":"Expression of interferon-regulated genes in juvenile dermatomyositis versus mendelian autoinflammatory interferonopathies","volume":"22","author":"Kim","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2023.117742_b1040","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000558","article-title":"PD1 pathway in immune-mediated myopathies Pathogenesis of dysfunctional T cells revisited","volume":"6","author":"Knauss","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.cca.2023.117742_b1045","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.791986","article-title":"Endoplasmic reticulum stress is involved in muscular pathogenesis of idiopathic inflammatory myopathies","volume":"10","author":"Ma","year":"2022","journal-title":"Frontiers Cell Development Biol"},{"key":"10.1016\/j.cca.2023.117742_b1050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41927-020-00125-8","article-title":"MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies","volume":"4","author":"Parkes","year":"2020","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.cca.2023.117742_b1055","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000811","article-title":"Distinct interferon signatures stratify inflammatory and dysimmune myopathies","volume":"5","author":"Rigolet","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.cca.2023.117742_b1060","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/genes10110864","article-title":"Meta-analysis of polymyositis microarray data reveals novel genetic biomarkers","volume":"10","author":"Song","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.cca.2023.117742_b1065","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2147\/IJGM.S346965","article-title":"Identification of Hub genes and biological pathways in inclusion body myositis using bioinformatics analysis","volume":"15","author":"Wu","year":"2022","journal-title":"International Journal of General Medicine"},{"issue":"7","key":"10.1016\/j.cca.2023.117742_b1070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/088307380201700714","article-title":"Dermatomyositis in two siblings and a brief review of familial dermatomyositis","volume":"17","author":"Tsao","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.cca.2023.117742_b1075","article-title":"Inborn errors of immunity: An expanding universe of disease and genetic architecture","author":"Akalu","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b1080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41437-022-00552-y","article-title":"Mendel's laws of heredity on his 200th birthday: What have we learned by considering exceptions?","volume":"129","author":"Wolf","year":"2022","journal-title":"Heredity (edinb)"},{"issue":"9","key":"10.1016\/j.cca.2023.117742_b1085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000402","article-title":"Calreticulin is a critical cell survival factor in malignant neoplasms","volume":"17","author":"Han","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cca.2023.117742_b1090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-cellbio-020520-111016","article-title":"Cellular mechanisms of NETosis","volume":"36","author":"Thiam","year":"2020","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b1095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cei.12319","article-title":"Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: A potential contributor to interstitial lung disease complications","volume":"177","author":"Zhang","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cca.2023.117742_b1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109738","article-title":"Metagenome-wide association study of gut microbiome features for myositis","volume":"255","author":"Li","year":"2023","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b1105","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/acr2.11413","article-title":"47XXY and 47XXX in scleroderma and myositis","volume":"4","author":"Scofield","year":"2022","journal-title":"ACR Open Rheumatology"},{"key":"10.1016\/j.cca.2023.117742_b1110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.autrev.2007.11.007","article-title":"Stress as a trigger of autoimmune disease","volume":"7","author":"Stojanovich","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.cca.2023.117742_b1115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41583-023-00729-2","article-title":"Central regulation of stress-evoked peripheral immune responses","volume":"24","author":"Chan","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.cca.2023.117742_b1120","article-title":"The geospatial distribution of myositis and its phenotypes in the united states and associations with roadways: Findings from a national myositis patient registry","volume":"16","author":"Hossain","year":"2022","journal-title":"Front Med (lausanne)"},{"key":"10.1016\/j.cca.2023.117742_b1125","article-title":"Racial disparities in diagnosis and treatment of patients with dermatomyositis of different skin tones","author":"Weisleder","year":"2023","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b1130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/BOR.0000000000000748","article-title":"Nonimmune mechanisms in idiopathic inflammatory myopathies","volume":"32","author":"Martinez","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"13","key":"10.1016\/j.cca.2023.117742_b1135","doi-asserted-by":"crossref","first-page":"e1374","DOI":"10.1212\/WNL.0000000000200013","article-title":"Immunophenotyping of inclusion body myositis blood T and NK cells","volume":"98","author":"Goyal","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2023.117742_b1140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000478012","article-title":"Autoimmunity in the elderly: Insights from basic science and clinics- A mini review","volume":"63","author":"Watad","year":"2017","journal-title":"Gerontology"},{"key":"10.1016\/j.cca.2023.117742_b1145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.exger.2017.10.024","article-title":"Age and immunity: What is \u201cimmunosenescence\u201d?","volume":"105","author":"Pawelec","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.cca.2023.117742_b1150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-immunol-092419-031130","article-title":"Age-associated B cells","volume":"38","author":"Cancro","year":"2020","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"10.1016\/j.cca.2023.117742_b1155","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1021\/cr0782574","article-title":"Calcium orthophosphates: Crystallization and dissolution","volume":"108","author":"Wang","year":"2008","journal-title":"Chem Rev."},{"key":"10.1016\/j.cca.2023.117742_b1160","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.3390\/ijms23137358","article-title":"Inclusion body myositis and neoplasia: A narrative review","volume":"23","author":"Damian","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cca.2023.117742_b1165","article-title":"The macrophage-osteoclast axis in osteoimmunity and osteo-related diseases","volume":"31","author":"Yao","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2023.117742_b1170","article-title":"Autoimmune diseases and hematological malignancies: Exploring the underlying mechanisms from epidemiological evidence","author":"Hemminki","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"7","key":"10.1016\/j.cca.2023.117742_b1175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.21037\/atm.2017.03.94","article-title":"MDA5 autoantibody\u2014Another indicator of clinical diversity in dermatomyositis","volume":"5","author":"Sontheimer","year":"2017","journal-title":"Ann Transl Med"},{"issue":"7","key":"10.1016\/j.cca.2023.117742_b1180","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/08916930903002511","article-title":"Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies","volume":"42","author":"Grundtman","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cca.2023.117742_b1185","first-page":"1","article-title":"The vasculopathy of juvenile dermatomyositis","author":"Papadopoulou","year":"2018","journal-title":"Front. Pediatr."},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103087","article-title":"Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases","volume":"21","author":"Piette","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.cca.2023.117742_b1195","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1182\/blood-2008-01-078204","article-title":"The vessel wall and its interactions","volume":"111","author":"Wagner","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117742_b1200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpeds.2017.01.046","article-title":"Race, income, and disease outcomes in juvenile dermatomyositis","volume":"184","author":"Phillippi","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.cca.2023.117742_b1205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1546-0096-12-2","article-title":"Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: A cross sectional study","volume":"12","author":"Faller","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b1210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12969-023-00904-w","article-title":"Juvenile dermatomyositis in afro-caribbean children: A cohort study in the French West Indies","volume":"21","author":"Felix","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"issue":"Suppl 1","key":"10.1016\/j.cca.2023.117742_b1215","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.2215\/CJN.05910809","article-title":"Calcium metabolism in health and disease","volume":"5","author":"Peacock","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2023.117742_b1220","article-title":"Are systematic screening for vitamin D deficiency and vitamin D supplementation currently feasible for ankylosing spondylitis patients?","volume":"2017","author":"Essouma","year":"2017","journal-title":"Int J Inflamm"},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b1225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5414\/CN108548","article-title":"Urinary calcium excretion in postmenopausal African American women","volume":"84","author":"Aloia","year":"2015","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.cca.2023.117742_b1230","doi-asserted-by":"crossref","unstructured":"D.B. Ojji B. Mayosi V. Francis M. Badri V. Cornelius W. Smythe N. Kramer F. Barasa A. Damasceno A. Dzudie E. Jones C. Mondo O.E. Ogah M.U. Sani G.L. Shedul G. Shedul B. Rayner I.G. Okpechi K. Sliwa N. Poulter & CREOLE study investigators. Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans N Engl J Med 380 25 2019 2429 2439 10.1056\/NEJMoa1901113.","DOI":"10.1056\/NEJMoa1901113"},{"issue":"9","key":"10.1016\/j.cca.2023.117742_b1235","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/jhh.2014.125","article-title":"The renin-angiotensin-aldosterone system and calcium-regulatory hormones","volume":"29","author":"Vaidya","year":"2015","journal-title":"J Hum Hypertens"},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b1240","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tcb.2022.07.004","article-title":"Calcium homeostasis and cancer: Insights from endoplasmic reticulum-centered organelle communications","volume":"33","author":"Zheng","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cca.2023.117742_b1245","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1007\/s00415-022-11029-7","article-title":"Comprehensive transcriptomic analysis shows disturbed calcium homeostasis and deregulation of T lymphocyte apoptosis in inclusion body myositis","volume":"269","author":"Johari","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2023.117742_b1250","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2020.09.002","article-title":"Cancer: An unknown territory; rethinking before going ahead","volume":"8","author":"Upadhyay","year":"2021","journal-title":"Genes & Diseases"},{"issue":"7","key":"10.1016\/j.cca.2023.117742_b1260","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/ijc.24141","article-title":"Autoimmunity and lymphomagenesis","volume":"124","author":"Goldin","year":"2009","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b1265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: A triangular relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cca.2023.117742_b1270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular occlusion by neutrophil extracellular traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cca.2023.117742_b1275","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231194821","article-title":"Objectivity, practicality, and significance of practice guidelines for the practicing neurologists: What we learnt from consensus criteria in CIDP, myasthenia gravis and inflammatory myopathies","volume":"16","author":"Dalakas","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.cca.2023.117742_b1280","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152107","article-title":"Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review","volume":"57","author":"Bentick","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b1285","doi-asserted-by":"crossref","first-page":"e12954","DOI":"10.1111\/bpa.12954","article-title":"MRI and muscle imaging for idiopathic inflammatory myopathies","volume":"31","author":"Malartre","year":"2021","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.cca.2023.117742_b1290","first-page":"548","article-title":"Isolated elevation of aldolase in the serum of myositis patients: A potential biomarker of damaged early regenerating muscle cells","volume":"30","author":"Casciola-Rosen","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b1295","article-title":"Clinical spectrum and outcome of idiopathic inflammatory myopathies in South Africans","volume":"10","author":"Birch","year":"2023","journal-title":"Front Med (lausanne)"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b1300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10974-022-09638-w","article-title":"Preservation of shortening velocity and power output in single muscle fibres from patients with idiopathic inflammatory myopathies","volume":"44","author":"Henning","year":"2023","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.cca.2023.117742_b1305","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s43162-023-00218-z","article-title":"Epidemiological, clinical and immunological aspects of antisynthetase syndrome: A multicentre study in Dakar","volume":"35","author":"Kane","year":"2023","journal-title":"The Egyptian Journal of Internal Medicine"},{"issue":"7","key":"10.1016\/j.cca.2023.117742_b1310","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/1756-185X.14348","article-title":"Polymorphism of protein tyrosine phosphatase non-receptor type 22 and protein arginine deiminase 4 gene among Ghanaian rheumatoid arthritis patients: A case-control study","volume":"25","author":"Sakyi","year":"2022","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b1315","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1097\/RHU.0000000000001708","article-title":"Epidemiology of Sj\u00f6gren Syndrome in Africa: A scoping review","volume":"28","author":"Essouma","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.cca.2023.117742_b1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102348","article-title":"Systemic lupus erythematosus in Native sub-Saharan Africans: A systematic review and meta-analysis","volume":"106","author":"Essouma","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cca.2023.117742_b1325","doi-asserted-by":"crossref","first-page":"176","DOI":"10.11604\/pamj.2020.37.176.22557","article-title":"Systemic sclerosis in sub-Saharan Africa: A systematic review","volume":"37","author":"Erzer","year":"2020","journal-title":"Pan Afr Med J"},{"issue":"8","key":"10.1016\/j.cca.2023.117742_b1330","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.7326\/M21-4675","article-title":"Race, genotype, and azathioprine discontinuation: A cohort study","volume":"175","author":"Dickson","year":"2022","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.cca.2023.117742_b1335","article-title":"Leveraging our common African origins to understand human evolution and health","volume":"3","author":"Wonkam","year":"2023","journal-title":"Cell Genom"},{"issue":"6","key":"10.1016\/j.cca.2023.117742_b1340","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0b013e32833f8f72","article-title":"Neurologists are from Mars. Rheumatologists are from Venus: Differences in approach to classifying the idiopathic inflammatory myopathies","volume":"22","author":"Christopher-Stine","year":"2010","journal-title":"Curr Opin Rheumatol"},{"issue":"7989","key":"10.1016\/j.cca.2023.117742_b1345","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41586-023-06767-1","article-title":"Remote collaboration fuses fewer breakthrough ideas","volume":"623","author":"Lin","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cca.2023.117742_b1350","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11024-016-9308-7","article-title":"The problem of expertise in knowledge societies","volume":"55","author":"Grundmann","year":"2017","journal-title":"Minerva"},{"key":"10.1016\/j.cca.2023.117742_b1355","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2022.0200","article-title":"Preface: causes of obesity, theories, conjectures and evidence","volume":"378","author":"Allison","year":"2023","journal-title":"Phil Trans R Soc B"},{"issue":"1","key":"10.1016\/j.cca.2023.117742_b1360","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pbiomolbio.2016.06.005","article-title":"Why do we need theories?","volume":"122","author":"Longo","year":"2016","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.cca.2023.117742_b1365","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3762\/bjoc.13.60","article-title":"Conjecture and hypothesis: The importance of reality checks","volume":"13","author":"Deamer","year":"2017","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.cca.2023.117742_b1370","doi-asserted-by":"crossref","unstructured":"A. Casadevall F. Fang Prisoner\u2019s science. mBio 2023 10.1128\/mbio.02633-23.","DOI":"10.1128\/mbio.02633-23"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123005442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123005442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:14:31Z","timestamp":1757862871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123005442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":273,"alternative-id":["S0009898123005442"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117742","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune inflammatory myopathy biomarkers","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117742"}}